Inside Berkshire Hathaway, some investors think legendary CEO Warren Buffett may be laying the groundwork for a blockbuster business opportunity, spawned from the health care venture he recently formed with the leaders of Amazon and JPMorgan Chase.

While most of the national discussion about the high-profile venture has focused on its potential to reshape the U.S. health care system, interviews with two long-time Berkshire shareholders show that within Buffett World, it’s also seen as a chance to develop profit-making lines of business and new investment ideas.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy